Jian Liu

This inventor holds 40 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 22 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Albany Molecular Research, Inc.. Active years: 2008-2026.

USPTO Granted Patents = 40 (Patent Applications = 23)

% Patents Active = 90.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 22 (Patent Applications = 37)

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 101(Granted Patents)

Company Filing History:

32 out of 2,405

Merck Sharp + Dohme Corp.

patents

6 out of 64

Merck Sharp & Dohme LLC

patents

3 out of 97

Albany Molecular Research, Inc.

patents

4. 1 out of 159

Jiangsu Hengrui Medicine Company Ltd.

Merck Sharp + Dohme B.v.

patents

7. 1 out of 100

Shanghai Hengrui Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

HIV Inhibitors

PCSK9 Antagonists

BTK Inhibitors

NAV1.8 Inhibitors

Thiadiazolidine

Melanocortin-4 Receptor

Histone Deacetylase

Antidiabetic Compounds

Voltage-Gated Sodium Channels

Azaindazole

Indazole

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723035 - Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as Nav1.8 inhibitors (2026-09-01),

2. 12692262 - Substituted ureas as orexin receptor agonists (2026-07-28),

3. 12686690 - Macrocyclic urea orexin receptor agonists (2026-07-21),

4. 12590099 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2026-03-31),

5. 12577259 - PCSK9 antagonist compounds (2026-03-17),

6. 12516046 - 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors (2026-01-06),

7. 12365674 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2025-07-22),

8. 12344595 - 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors (2025-07-01),

9. 12331044 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2025-06-17),

10. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes (2025-04-21),

11. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

12. 12209145 - PCSK9 antagonist compounds (2025-01-28),

13. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors (2025-01-14),

14. 12178842 - PCSK9 antagonist compounds (2024-12-31),

15. 11976069 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2024-05-07),

Title: The Innovative Journey of Jian Liu

Introduction: Jian Liu, a talented inventor based in Edison, NJ, has made significant contributions to the field of technology with his groundbreaking innovations and patents.

Latest Patents: Jian Liu's most recent patents include a cutting-edge software application for data encryption and a revolutionary device for renewable energy storage.

Career Highlights: With a background in electrical engineering, Jian Liu has a successful career marked by a series of innovative projects. He has worked for several tech companies, leading research and development teams to create cutting-edge solutions.

Collaborations: Jian Liu is known for his collaborative spirit, having partnered with top researchers and engineers in the industry to bring his ideas to life. His ability to work effectively in teams has led to the successful implementation of various projects.

Conclusion: Jian Liu's passion for innovation and his dedication to pushing the boundaries of technology make him a standout inventor in the field. His impressive portfolio of patents and his commitment to collaboration continue to inspire the next generation of inventors.